Clinical Trial

Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-17; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2026-04-28
Trial Details
NCT Number NCT06212102
Lead Sponsor Bedaya Hospital
Collaborators: Cairo University
Conditions Infertility
Enrollment 120 participants
Start Date 2024-05-08
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04